180 related articles for article (PubMed ID: 35509151)
1. CDK5RAP3, an essential regulator of checkpoint, interacts with RPL26 and maintains the stability of cell growth.
Yan H; Xu JJ; Ali I; Zhang W; Jiang M; Li G; Teng Y; Zhu G; Cai Y
Cell Prolif; 2022 May; 55(5):e13240. PubMed ID: 35509151
[TBL] [Abstract][Full Text] [Related]
2. Cdk5rap3 is essential for intestinal Paneth cell development and maintenance.
Quintero M; Liu S; Xia Y; Huang Y; Zou Y; Li G; Hu L; Singh N; Blumberg R; Cai Y; Xu H; Li H
Cell Death Dis; 2021 Jan; 12(1):131. PubMed ID: 33504792
[TBL] [Abstract][Full Text] [Related]
3. CDK5RAP3 Deficiency Restrains Liver Regeneration after Partial Hepatectomy Triggering Endoplasmic Reticulum Stress.
Yang S; Yang R; Wang H; Huang Y; Jia Y
Am J Pathol; 2020 Dec; 190(12):2403-2416. PubMed ID: 32926856
[TBL] [Abstract][Full Text] [Related]
4. CDK5RAP3, a Novel Nucleoplasmic Shuttle, Deeply Regulates HSF1-Mediated Heat Stress Response and Protects Mammary Epithelial Cells from Heat Injury.
Shen Y; Zou Y; Li J; Chen F; Li H; Cai Y
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182370
[TBL] [Abstract][Full Text] [Related]
5. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
Feng X; Jiang J; Sun L; Zhou Q
Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation.
Jiang H; Wu J; He C; Yang W; Li H
Cell Res; 2009 Apr; 19(4):458-68. PubMed ID: 19223857
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-Dependent Kinase 5 Regulatory Subunit Associated Protein 3: Potential Functions and Implications for Development and Disease.
Sheng L; Li J; Rao S; Yang Z; Huang Y
Front Oncol; 2021; 11():760429. PubMed ID: 34722315
[TBL] [Abstract][Full Text] [Related]
8. CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma.
Zhuo R; Zhang Z; Chen Y; Li G; Du S; Guo X; Yang R; Tao Y; Li X; Fang F; Xie Y; Wu D; Yang Y; Yang C; Yin H; Qian G; Wang H; Yu J; Jia S; Zhu F; Feng C; Wang J; Xu Y; Li Z; Shi L; Wang X; Pan J; Wang J
Cancer Lett; 2024 Jun; 591():216882. PubMed ID: 38636893
[TBL] [Abstract][Full Text] [Related]
9. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
10. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
[TBL] [Abstract][Full Text] [Related]
12. CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.
Mak GW; Lai WL; Zhou Y; Li M; Ng IO; Ching YP
PLoS One; 2012; 7(7):e42210. PubMed ID: 22860085
[TBL] [Abstract][Full Text] [Related]
13. Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint.
Jiang H; Luo S; Li H
J Biol Chem; 2005 May; 280(21):20651-9. PubMed ID: 15790566
[TBL] [Abstract][Full Text] [Related]
14. CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3.
Egusquiaguirre SP; Liu S; Tošić I; Jiang K; Walker SR; Nicolais M; Saw TY; Xiang M; Bartel K; Nelson EA; Frank DA
Neoplasia; 2020 Jan; 22(1):47-59. PubMed ID: 31765941
[TBL] [Abstract][Full Text] [Related]
15. CDK5RAP3, a UFL1 substrate adaptor, is crucial for liver development.
Yang R; Wang H; Kang B; Chen B; Shi Y; Yang S; Sun L; Liu Y; Xiao W; Zhang T; Yang J; Zhang Y; Zhu M; Xu P; Chang Y; Jia Y; Huang Y
Development; 2019 Jan; 146(2):. PubMed ID: 30635284
[TBL] [Abstract][Full Text] [Related]
16. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
[TBL] [Abstract][Full Text] [Related]
17. CDK5RAP3 Participates in Autophagy Regulation and Is Downregulated in Renal Cancer.
Li J; Hu X; Su M; Shen H; Qiu W; Tian Y
Dis Markers; 2019; 2019():6171782. PubMed ID: 31061682
[TBL] [Abstract][Full Text] [Related]
18. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes.
Tran T; Kolupaeva V; Basilico C
Cell Cycle; 2010 Nov; 9(21):4379-86. PubMed ID: 21051949
[TBL] [Abstract][Full Text] [Related]
19. CDK5RAP3 Inhibits the Translocation of MCM6 to Influence the Prognosis in Gastric Cancer.
Chen QY; Liu LC; Wang JB; Xie JW; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH
J Cancer; 2019; 10(19):4488-4498. PubMed ID: 31528213
[TBL] [Abstract][Full Text] [Related]
20. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer.
Zheng CH; Wang JB; Lin MQ; Zhang PY; Liu LC; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM
J Exp Clin Cancer Res; 2018 Mar; 37(1):59. PubMed ID: 29540196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
